(Q38054458)

27 August 2017

title

NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury (English)

1 reference

27 August 2017

1 reference

Pamela W M Kleikers

1

1 reference

27 August 2017

K Wingler

2

1 reference

27 August 2017

J J R Hermans

3

1 reference

27 August 2017

I Diebold

4

1 reference

27 August 2017

S Altenhöfer

5

1 reference

27 August 2017

K A Radermacher

6

1 reference

27 August 2017

B Janssen

7

1 reference

27 August 2017

A Görlach

8

1 reference

27 August 2017

H H H W Schmidt

9

1 reference

27 August 2017

publication date

23 October 2012

1 reference

Journal of Molecular Medicine

27 August 2017

published in

1 reference

27 August 2017

volume

90

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1391-1406

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-012-0963-3

27 August 2017

exact match

0 references

cites work

Vascular ischaemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Effects of NXY-059 in experimental stroke: an individual animal meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

To prevent, protect and save the ischemic heart: antioxidants revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The impact of ischaemia-reperfusion on the blood vessel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Myocardial reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Oxidative stress as a mediator of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Myocardial reperfusion: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Redox signaling in vascular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mitochondria and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Structure and function of xanthine oxidoreductase: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidases in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidases: functions and pathologies in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Vascular NADPH oxidases as drug targets for novel antioxidant strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Strategies to reduce oxidative stress in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase inhibitors: new antihypertensive agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidases: new kids on the block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Vascular NAD(P)H oxidases: specific features, expression, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NOX5 variants are functionally active in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Subcellular localization of Nox4 and regulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase: a universal oxygen sensor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NAD(P)H oxidases regulate HIF-2alpha protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Role of NADPH oxidase-mediated superoxide production in the regulation of E-selectin expression by endothelial cells subjected to anoxia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Hypoxia-inducible factor 1 (HIF-1) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Rac1 activity is required for the activation of hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase is involved in post-ischemic brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The 1027th target candidate in stroke: Will NADPH oxidase hold up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Redox signaling in angiogenesis: role of NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mouse strain determines the outcome of wound healing after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Reactive oxygen generated by Nox1 triggers the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox4 acts as a switch between differentiation and proliferation in preadipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Regulation of myocardial growth and death by NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Xanthine oxidoreductase in respiratory and cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The role of nitric oxide in myocardial repair and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Cross talk between mitochondria and NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Heart mitochondria: gates of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mitochondrial ROS-induced ROS release: an update and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Vitamin C prophylaxis promotes oxidative lipid damage during surgical ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NOX1, 2, 4, 5: counting out oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Oxidative stress and cardiovascular injury: Part II: animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0963-3

Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction

21 January 2018

1 reference

12 December 2020

Mice lacking in gp91 phox subunit of NAD(P)H oxidase showed glomus cell [Ca(2+)](i) and respiratory responses to hypoxia

1 reference

12 December 2020

Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia

1 reference

12 December 2020

Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro

1 reference

12 December 2020

Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.

1 reference

12 December 2020

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction

1 reference

12 December 2020

Nox 4 regulation of vascular smooth muscle cell differentiation marker gene expression

1 reference

12 December 2020

Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells

1 reference

12 December 2020

A gp91phox Containing NADPH Oxidase Selectively Expressed in Endothelial Cells Is a Major Source of Oxygen Radical Generation in the Arterial Wall

1 reference

12 December 2020

Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species

1 reference

12 December 2020

Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription

1 reference

12 December 2020

Redox regulation of vascular angiogenesis

1 reference

12 December 2020

Expression of phagocyte NADPH oxidase components in human endothelial cells

1 reference

12 December 2020

The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II

1 reference

12 December 2020

Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice

1 reference

12 December 2020

Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells

1 reference

12 December 2020

Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1

1 reference

12 December 2020

Characteristics of carotid body chemosensitivity in NADPH oxidase-deficient mice

1 reference

12 December 2020

10.1007/S00109-012-0963-3

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1026833361

0 references

1 reference